Australian women's prediagnostic values and influencing sociodemographic variables relating to treatment choices for early breast cancer treatment by Budden, Lea M. et al.
	 Vol	8	•	No	1	 March	2007	 	
Introduction
Throughout the industrialised world, breast cancer remains a 
major cause of morbidity and mortality in women. In western 
countries the incidence of women developing this disease 
during their lifetimes is one in eleven in Australia 2, one in nine 
in the UK 3; one in eight in the USA 4. Each year over 11,000 
Australian women are diagnosed with breast cancer 2 and up to 
one third of these women are aged <50 years 2,5.
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Abstract
Women are often asked by their doctors to choose their preferred treatment for early breast cancer. Evidence shows that many women 
are distressed and confused about how to make this treatment decision and frequently seek help from nurses. Very little is known 
about women’s value-centred decision-making in relation to selecting treatment for breast cancer and for nurses it is difficult to 
know how to assist these women with this process. In this study, 377 women participated prior to undergoing routine mammography 
screening and the data were collected using the Pre-Decision Portfolio Questionnaire (PDPQ) by Pierce 1. The partipants identified 
that expected treatment outcomes were the most important factor in choosing early breast cancer treatment. The majority reported 
that it was very important that a treatment would reduce the chances the cancer would return (95.6%), increase the length of their 
life (82.1%) and lead them to being healthy (80.4%). In addition, the participants indicated that it was important, or very important, 
that the emotional consequences of the treatment did “not make you depressed” (88.6%) or “sad” (90.4%) and should “keep you 
from worrying” (97%) and “give you peace of mind” (98.6%). Other factors, such as treatment’s side effects, were identified as less 
important. Age, employment, education and having a family history of breast cancer were found to be significant influencing variables 
on the values of the participants. It was concluded that assessing and understanding the treatment values of women can help nurses 
focus on areas of importance to the woman and lead to informed decision-making when they are choosing treatment for early breast 
cancer.
 Women who are diagnosed with an early stage of breast cancer 
have more treatment choices and a better prognosis than 
women who have developed an advanced form of the disease. In 
Australia, the TNM Clinical Classification defines early breast 
cancer as a tumour >2cm and <5cm in diameter, with no fixed 
lymph nodes and no evidence of metastases (this corresponds 
to tumours T11-2, N0-12, M0) 6. The surgical recommendations 
for women diagnosed with early breast cancer are a mastectomy 
or breast conservation surgery (lumpectomy); both treatment 
options include auxiliary dissection 6.
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After diagnosis of breast cancer, women are vulnerable to 
high levels of stress 7,8,9 psychological distress, and they suffer 
the consequent upheaval to their emotional wellbeing 10,11. 
The emotional turmoil places them at risk of developing 
interpersonal difficulties, body image and sexuality problems, 
depression and anxiety 12. Of Australian women diagnosed, A 
34% will be highly distressed or will experience high levels of 
psychological disturbance; 35.4% will be experiencing distress 
at three months post-diagnosis and up to 20% at twelve months 
post-diagnosis 12 .
Breast cancer treatment decision-making
The recent fundamental paradigm shift in western countries from 
the traditional, paternalistic model of healthcare to consumer 
focused healthcare encourages doctors to shift the treatment 
decision-making responsibility to the patient. Following a 
diagnosis of early breast cancer, women are encouraged to 
participate with their doctor in choosing between equally 
effective treatment options – mastectomy and lumpectomy 
with adjuvant radiotherapy and possibly chemotherapy 13,14 
– and women choose a treatment plan based on their values, 
preferences and lifestyle 9.
Many sociodemographic factors, such age 5,16,17 and 
education 18,19,20 have been identified as influencing this decision-
making process. Other factors such as expectations of quality of 
life, psychological and physical state, perception of risks and 
preferences about the treatment options 21,22,23 are also known to 
influence choices  for early breast cancer treatment. 
There is evidence that women experience better psychological 
outcomes, such as less depression and anxiety, when they 
have been involved with their doctor in choosing between 
breast cancer treatments 7,24,25,26,27. However, some women do 
not wish to participate in the responsibility of such decisions 
and the burden of choice can cause further anxiety 23,28. The 
varieties of treatment and  information can cause confusion for 
women, who are already distressed. This is especially the case 
when asked to make quality of life decisions from unfamiliar 
medical language 29 and uncertain outcomes 7,8,30. In Australia, 
these circumstance can be further compounded by a number of 
health system barriers, such as a lack of continuity of care for 
women with breast cancer, the short time between diagnosis 
and treatment, inconsistency of information given, and the 
geographical distance of treatment options 6,12. 
However, in the last five years in Australia, a number of 
initiatives to address these deficiencies have been put in place: 
communication skills training for oncologists 31; the assessment 
of cancer patients communication needs 32; distress levels 33; the 
development of the Psychosocial Clinical Practice Guidelines 
for women with breast cancer 12; the development of the role of 
the specialist breast care nurse and their specific competency 
based standards 34.
Many women may not have suitable access to health services, 
or possess the emotional and cognitive resources and skills 
following the diagnosis of breast cancer to make informed 
quality treatment decisions 35. Many women are uncertain about 
choosing treatment and often seek supplementary information 
and guidance from nurses 9. Nurses currently do not have 
structured methods to provide this support and may feel 
inadequate. The support of nurses in helping women in this 
decision-making process is vital because women often reflect 
on their decision both before and after consulting with their 
doctors.
Decision-making models
Although there are many normative and descriptive decision-
making models, these do not adequately explain the process 
of choosing medical treatment in a naturalistic setting when 
the person is in a distressed state 8. Normative models describe 
what people should do; descriptive models describe what people 
actually do 36. Recently, decision science has evolved a new area 
called 'naturalistic decision-making' to describe how people 
actually make a decision in a natural setting. Naturalistic 
decision-making consists of four key features: it is a dynamic 
process with changing conditions; it has real time reactions 
to these condition changes; it has ill-defined goals and ill 
structured tasks; and it involves knowledgeable people 37. 
Decision-making for medical treatment
Three major components make up the decision-making process 
for medical treatment:
The decision problem (which has at least two possible 
choices).
The decision-maker (patient).
The context (or environment) 21,22.
The conceptual model adapted in this study was the "empiric 
description of the decision-making" 22. This model enables nurses 
to assist patients in their decision-making in difficult, distressing 
and uncertain situations. The first stage of determining the 
salience of the problem can be applied to assessing women’s 
values involved in choosing medical treatment 22. This model 
examines the problem for the decision-maker (patient) and 
discusses the sequential stages of diagnostics:
1.
2.
3.
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Salience of the problem (understanding of the problem, 
the risks and possible outcomes of each alternative).
Decomposition of alternatives (understanding the 
components of alternatives).
Information seeking (need or avoidance for further 
information).
Strategy (existence of a treatment plan).
Declaration of choice (decision).
Post-decision appraisal (satisfaction of decision choice/s).
Included in the model are questions that nurses can apply to 
determine (diagnose) the decision support (such as information 
and psychosocial interventions) necessary to assist the patient 
in the process of decision-making.
The role of the nurse in decision support
Nurses have an ethical responsibility, “to promote health, to 
prevent illness, to restore health and alleviate suffering” 38. 
For nurses to fulfil these ethical imperatives, it is critical that 
women receive sufficient information in a way they can process, 
interpret, and use it as a base for informed consent for choosing 
care and treatment for early breast cancer. However, the nature 
of the value-centred decision-making process of women with 
cancer is complex and not fully understood, and research 
of aspects of women with breast cancer continues 39,40,41,42,43. 
Published studies and future research should guide and assist 
nurses in their decision support assessment and interventions.
For nurses to help women choose medical treatments that are 
consistent with their values and lifestyle and improve their 
satisfaction, more information and understanding is required 
about what factors women believe are important and what 
sociodemographic variables influence choice of treatment. 
Values can be defined as 'ideals, beliefs, customs, modes of 
conduct, qualities, or goals that are highly prized or preferred 
by individuals, groups or society’, which are culturally based44. 
In decision science, a ‘value’ is described as attractiveness of 
a possible outcome 45 and a ‘utility’ is defined as a patient’s 
preference for a particular alternative 21,46. Individual decisions 
are value-centred and choices are mediated (influenced) by 
their religious, personal and cultural values 22 and  satisfaction is 
related to choices that are consistent with a person’s values and 
expectations 47. If nurses are able to accurately assess women’s 
values and understand some of the influencing sociodemographic 
variables, they are able to target and deliver clear information 
that is important to women to help them make informed 
treatment decisions. Nurses need to provide information about 
1.
2.
3.
4.
5.
6.
treatment outcomes in a clear format that women can process 
and understand in order to help them make informed decisions 
that are value–centred and suit their lifestyles.
The study
Aim
The aim of this cross-sectional explorative survey was to 
investigate the prediagnostic values and sociodemographic 
variables of Australian women that influenced their choice 
of treatment for early breast cancer. Before evidence-based 
decision support interventions can be further developed and 
evaluated, it is essential to obtain an understanding of women’s 
unaided decision-making for choosing medical treatment. 
Currently, there is limited information available for nurses that 
provides a structured method to guide the matching of women’s 
values with the care provided. To redress this gap, this study 
provides a baseline to compare the treatment values of women 
and the sociodemographic factors that influence them.
Research Question
The research question developed for this study was: What are 
women’s prediagnostic values and influencing sociodemographic 
variables involved in choosing early breast cancer treatment in 
a hypothetical scenario?
Definitions
The research variables for the study were defined as:
Treatment values – the factors important to women when 
they are choosing hypothetical medical treatment for early 
breast cancer. 
Pre-diagnostic decision-making – the choosing of medical 
treatment if they are hypothetically diagnosed with early 
breast cancer.
Socio-demographic variables – the background of 
participants such as age, education level, employment 
status, occupation and personal and family history of breast 
cancer.
Hypothetical scenario – questions relating to what 
treatment choices they would make if diagnosed with early 
breast cancer.
Participants
The total non-probability (convenience) sample consisted of 
377 women (response rate 66%) who were undertaking routine 
mammography screening at a Brisbane breast clinic. Brisbane is 
the capital city of the state of Queensland in Australia. Women 
•
•
•
•
12	 Vol	8	•	No	1	 March	2007
The	Australian	 Journal	of
Cancer	Nursing
who had declined the invitation to participate in the study 
stated that they had attended the breast clinic during their 
work time and wanted to return to their workplace as soon as 
possible. 
The rationale for selecting this sample was that mammography 
is a screening procedure for breast cancer and so the women 
are already aware of the possibility of being diagnosed with 
breast cancer. Data gathered from these women are the closest 
match to women actually diagnosed with breast cancer without 
increasing the distress to women already in the midst of 
diagnosis or treatment. This sample also provided contact with 
a large number of women who were attending routine breast 
cancer screening. 
“How important is it to you 
that the treatment….”
Result Influencing variables#
Treatment outcome
“allow you to get well 
quickly?” 
Very important
Average important
Less important
64.9%
28.2%
6.9%
“be a tried and true 
treatment?”
Very important
Average important
Less important
74.0%
19.6%
6.4%
Believers
in God
86.3%
82.4%
59.1%
p=0.0038
“let you be healthy?”
Very important
Average important
Less important
80.4%
19.1%
0.5%
“let you live a long life?”
Very important
Average important
Less important
82.1%
15.7%
2.2%
Age 
Mean
(±SD) ##
51.3 ±7
54.4 ±9.1
57.8 ±8.6
p=0.0033
Professional 
Occupation
27.2%
21.1%
37.5%
p=0.0082
“help you get completely 
well?”
Very important
Average important
Less important
90.1%
9.6%
0.3%
Age 
Mean
(±SD) ##
51.5 ± 8.0
56.2 ± 8.1
42
p=0.022
Employed 69.5%
37.5%
100%
p=0.067*
“cure you?”
Very important
Average important
Less important
90.9%
8.2%
0.8%
Age 
Mean
(±SD) ##
51.5± 8.0
54.8± 8.6
62.3±3.2
p=0.0090
Employed 69.1%
40.7%
33.3%
p= 0.0122*
“get rid of the cancer?”
Very important
Average important
Less important
93.6%
6.4%
0%
Employed 68.3%
45.0%
0%
p=0.0234
“reduce chances the cancer 
will come back?”
Very important
Average important
Less important
95.6%
4.4%
0%
Employed 68.2%
28.6%
0%
p=0.098
Table 1: Participant’s (N = 377) rating of the importance of different values relating to potential breast cancer treatment and influencing 
sociodemographic background variables. 
# Influencing variables of categorical nature given as percentages in the categories 'very important', 'average important', and 'less 
important'. For example, for the treatment outcome “be a tried and true treatment?”, 86.3% who rated this 'very important' also 
reported belief in God; 82.4% who rated this 'average important' reported belief in God; and 59.1% who rated this 'less important' 
reported belief in God (p = 0.0038).
## Age is presented by mean value and standard deviation (SD). For example, women who rated the treatment outcome “let you 
live a long life” as 'very important' had a mean age of 51.3 years; 'average important' a mean age of 54.4 years; and 'less important' 
a mean age of 57.8 years (p = 0.0033).
* These p-values are results of Fisher’s exact test.
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Instrument and data collection
The Pre-Decision Portfolio Questionnaire 1 was used to collect 
data for the study. This instrument was developed following the 
analysis of interviews from 48 women diagnosed with early breast 
cancer in a grounded theory study 9. Information was collected 
from participants about their sociodemographic background 
and their decision-making treatment values relating to early 
breast cancer treatment 1. A small group of Australian women 
representative of the study’s population were used to validate 
the instrument prior to data collection of the sample. The 
internal consistency reliability of the value items was assessed 
by the Cronbach alpha method and the results were: Treatment 
Outcomes = 0.84; Side Effects = 0.80; Emotional Consequences 
= 0.73; Effects of Treatment on Energy Levels = 0.93; General 
Perceptions = 0.84; Characteristics of Treatment = 0.75.
The questionnaire was a series of closed-ended questions about 
“How important is it to you 
that the treatment….”
Result Influencing variables
Side effects
“not be painful?”
Very important
Average important
Less important
32.5%
33.9%
33.6%
“not make you sick?”
Very important
Average important
Less important
40.2%
32.0%
27.8%
University
Education
26.3%
35.1%
47.8%
p=0.0112
“not have many side effects?”
Very important
Average important
Less important
45.2%
36.8%
18.0%
“not have serious side 
effects?”
Very important
Average important
Less important
59.9%
31.0%
9.1%
“not be dangerous?”
Very important
Average important
Less important
82.2%
14.2%
3.6%
Professional 
Occupation
26.6%
21.2%
46.2%
p=0.0243
Emotional consequences
“not make you depressed?”
Very important
Average important
Less important
56.1%
32.5%
11.4%
Family 
history of 
breast cancer
51.0%
47.4%
25.6%
p=0.0148
“not make you sad?”
Very important
Average important
Less important
60.1%
30.3%
9.6%
Family 
history of 
breast cancer
50.2%
48.6%
23.5%
p=0.0412
University
Education
31.0%
33.3%
57.6%
p=0.0363
“keep you from worrying?”
Very important
Average important
Less important
76.6%
20.3%
3.0%
Urban living 78.1%
92.4%
62.5%
p=0.0136
“give you peace of mind?”
Very important
Average important
Less important
87.9%
10.7%
1.4%
Table 1 (continued)
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women’s demographic details and decision-making values for 
treatment. The questionnaire was divided into two areas: socio-
demographic variables and treatment values. Socio-demographic 
variables included thirteen items: age, education, marital status, 
address postcode, occupation, employment status, income, 
private health insurance status, and experience with breast 
cancer or cancer in the family and/or a close person, medical 
diagnosis and significant support person. Treatment Values 
covered thirty-one items scored on a 5-point scale from 'not 
at all important' to 'critically important'. These items included 
questions relating to general characteristics of the treatment, 
the effect of treatment on energy, side effects, treatment 
outcome, and emotional and perception consequences of the 
treatment. For comparative analysis, the scale was reduced to a 
3-point scale ('not so important', 'average important', and 'very 
important'). A full list of the items can be found in Tables 1 
and 2.
When women arrived at the breast screening clinic, they 
were given written information about the study while waiting 
“How important is it to you 
that the treatment….”
Result Influencing variables
Effects of treatment on energy levels
“not limit your activities?”
Very important
Average important
Less important
50.7%
35.6%
13.7%
“not make you tired?”
Very important
Average important
Less important
53.8%
34.7%
11.5%
“keep you physically active?”
Very important
Average important
Less important
54.7%
36.3%
9.1%
“keep your energy level up?”
Very important
Average important
Less important
56.4%
36.5%
7.1%
“not interfere with your daily 
life?”
Very important
Average important
Less important
50.4%
31.6%
18.0%
“let you control your life”
Very important
Average important
Less important
64.7%
29.8%
5.5%
Believers 
in God
84.6%
78.1%
100%
p=0.0404
General perceptions
“not change the way people 
think about you?”
Very important
Average important
Less important
16.4%
19.4%
64.2%
“not interfere with your sex 
life?”
Very important
Average important
Less important
27.6%
31.0%
41.4%
“allow you to wear clothes 
and look normal?”
Very important
Average important
Less important
31.1%
40.5%
28.4%
University
Education
27.5%
34.8%
43.0%
p=0.0286
“not make you feel bad about 
your body?”
Very important
Average important
Less important
37.6%
28.7%
33.7%
“allow you to still feel like a 
woman?”
Very important
Average important
Less important
47.9%
36.6%
15.4%
University
Education
26.8%
44.0%
34.5%
p=0.0104
Table 2
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for their mammography screening. If women consented to 
participate in the research, they were asked to complete the 
consent form and a questionnaire and to place both items in 
a sealed box located in the waiting room. The information 
sheet for the study included an explanation of the two surgical 
options for early breast cancer; mastectomy (total removal of 
the breast) and lumpectomy (removal of breast lump).
Pilot Study
A pilot study of 47 women who completed a questionnaire 
prior to routine mammography screening was conducted and 
evaluated, using the protocol described above. No changes were 
required to the data collection procedure and protocol, so the 
entire pilot data collected was included in the study.
Ethical considerations
The researchers applied and obtained ethical approval for the 
study from the Experimentation Ethics Committee of James 
Cook University and permission from the site for conducting of 
the study. During the study the clinic’s specialist breast nurses 
were available to give support to the women in the study if they 
felt distressed by the questionnaire. No women approached the 
specialist breast nurses or indicated in the open-ended questions 
at the end of the questionnaire that they had experienced 
distress while participating in the study.
Data analysis
Descriptive and inferential analyses of the data were performed 
following the data cleaning process. Because of low response 
rates in the extreme categories, the treatment outcomes were 
reduced from a 5-point scoring scale ('not at all important' to 
'critically important') to a 3-point scale ('very importan', 'average 
importan', 'less important'). Bivariate associations between 
sociodemographic variables and decision-making treatment 
values were assessed using Chi-square tests and Fisher’s exact 
tests, if both characteristics were categorical (Fisher’s exact test 
was used when expected frequencies were small), and analysis 
of variance, if one characteristic was categorical and the other 
numerical (age). Statistical analysis was performed using SPSS 
for Windows release 6.1.3 and, in the statistical analysis, a 
significance level of 0.05 was assumed.
Findings
Participants
The participants (N=377) in the study ranged in age from 33 
to 76 years (mean age = 52 years, SD ± 8.2 years); 80.6% were 
living in the urban area of Brisbane; 57.9% had completed high 
school, 8.3% had completed Technical and Further Education 
(TAFE) and 33.8% had completed university; 86% reported 
residing with others; 83.9% reported a belief in God; 66.1% 
reported being in employment; 82.9% held private health 
insurance; 23.9% reported a household income of >$AUS 
27,500 per person per year. Six of the participants reported a 
personal history of breast cancer and 47.1% a family history of 
breast cancer.  
Almost three-quarters (73.3%)(N=377) of the participants 
reported that they would choose to undergo a lumpectomy with 
radiation, compared with 26.7% who would choose mastectomy 
treatment. Due to the amount of data collected, specific details 
“How important is it to you 
that the treatment….”
Result Influencing variables
General characteristics of treatment
“be convenient?”
Very important
Average important
Less important
14.9%
30.6%
54.5%
“be affordable?”
Very important
Average important
Less important
18.7%
29.1%
52.2%
Living with 
somebody
77.6%
81.6%
91.2%
p=0.0083
With private 
health 
insurance
70.6%
82.9%
87.4%
p=0.0071
“be quick?”
Very important
Average important
Less important
22.6%
30.4%
46.9%
University
Education
26.3%
35.5%
40.0%
p=0.0284
“allow you to get back to work 
soon?”
Very important
Average important
Less important
38.1%
29.8%
32.1%
Table 2 (continued)
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about the decision-making styles and processes of the sample 
have been separated and discussed elsewhere 68.
Breast cancer treatment values
Table 1 presents the participant’s rating of their values when 
deciding about early breast cancer treatment. The majority 
(82.2%) rated as 'very important' that the treatment "not be 
dangerous", that it should “get rid of the cancer “ (93.6%), that 
it would “reduce chances the cancer will come back” (95.6%), 
that it would “cure you” (90.9%), and that it would “give you 
peace of mind” (87.9%). 
Most high percentages in the 'very important' category were 
related to statements concerning treatment outcome. The vast 
majority rated as 'very important' that the treatment would 
“reduce chances the cancer will come back” (95.6%) and that 
it would “get rid of the cancer” (93.6%). Many were concerned 
about the side effects of treatment; an overwhelming majority 
desired that the treatment should “not be dangerous” (82.2%) 
and that it should “give you peace of mind” (87.9%). Practical 
consideration of expense and time taken to recover was rated 
'less important'. Only 18.7% rated as 'very important' that 
treatment be affordable or to “allow you to get back to work 
soon” (38.1%). 
Breast cancer treatment values and 
sociodemographic factors
Table 1 presents the  influence of sociodemographic 
characteristics of the participants' ratings of values of breast 
cancer treatment. The sociodemographic factors considered 
– age, employment status, occupation, education, belief in God, 
family history of breast cancer, residence in urban or rural areas, 
living with alone or with others, and private health insurance 
coverage – were found to be influencing sociodemographic 
background variables. Younger participants were more likely 
than older participants to to rates as 'very important' the 
treatment outcome, “let you live a long life” (p=0.003), but 'less 
important' that it “helps you get completely well” (p=0.022). 
Participants who rated as 'very important' that the treatment 
should “cure you” were on average >10 years younger and more 
likely to be employed than participants who rated this as 'less 
important' (p=0.0090, p=0.0122, respectively). 
Of the participants who rated “get rid of the cancer” as 'very 
important', 68.3% were currently employed compared with 
45.0% rated this as of 'average importance' (p = 0.0234). 
Employment showed a similar trend in the treatment outcome 
“reduce chances the cancer will come back”, although this was 
not significant (p = 0.098). 
Discussion
Treatment values
The study identified that treatment outcomes were the most 
important consideration for selecting hypothetical medical 
treatment. These findings are consistent with other studies 
of women diagnosed with breast cancer 23,48. Understanding 
information about the precise types of treatment that are 
important to individual women is critical for nurses, so that they 
can provide more focused information support to aid women’s 
decision–making, reduce their distress levels and increase their 
psychological wellbeing 49. By contrast, non-focused information 
can increase women’s uncertainty and anxiety, and lead to 
depression and post-decision regret 8,9,50. 
In decision-making, if the attractiveness between the alternatives 
are small, people will often seek further information 9,51,55. Nurses 
require careful consideration to frame the problems of each 
treatment alternative, because this discussion may alter the 
women’s preferences 52,53. A study about  women choosing 
adjuvant therapy following surgery reports that the global 
presentation of information is more important to the decision-
making for women than other factors 54. 
In this study 93.1% of the participants also rated as 'average 
important' and 'very important' that the treatment outcome 
“allow you to get well quickly”. This result is not surprising since 
a diagnosis and treatment of breast cancer can have dramatic 
financial effects on the lifestyle of women and their ability to 
care for children and perform their daily activities 5. In addition, 
given the remoteness of parts of Australia, women often have 
difficulty accessing information and services. Nurses who care 
for women in North Queensland anecdotally report that some 
women in this area may choose to undergo mastectomy (even if 
this is not the preferred option), so they can return home more 
quickly (particularly if living and running the family farm), 
rather than the time and travel needed to undertake radiation 
therapy.
Women’s needs and preferences for decision involvement, 
specific types of information and psychosocial support , change 
throughout the course of the treatment and require frequent 
individualised 55 review and assessment by nurses. Inability to 
differentiate between treatment alternatives can lead to less 
satisfactory decisions 56 and post-decision regret 9. Women need 
to understand clearly the differences between each alternative 
and the information should be individually customised to explain 
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the consequences characteristic of each type of treatment 50 so 
that they can choose a treatment that matches their values and 
preferences 22. 
Women will individually experience a myriad of psychological 
and emotional changes following diagnosis and in the treatment 
phase 12, and following breast cancer treatment one-third of 
women can experience severe psychological adjustment disorders 
such as anxiety and depression 57,58. In Australia, a recent study 
of 132 women diagnosed with early breast cancer and prior to 
any initial treatment, found 23.5% were depressed and 28.8% 
were experiencing anxiety 59 measured using the Brief Symptom 
Inventory -18 60. Therefore, nurses need to consider how they 
can provide short- and long-term psychological support and 
interventions for women after their initial treatment to increase 
their quality of life and improve their psychological wellbeing 12. 
Women are being offered early discharge after treatment from 
some centres, and nurses need to assess their social support. If 
early discharge from hospital after surgery for breast cancer is 
safe and is well received by patients, early discharge seems to 
enhance the opportunity for social support within the family 61.
Almost three-quarters of the participants reported that they 
would hypothetically choose a lumpectomy with radiation 
therapy if they were diagnosed with early breast cancer, but 60% 
of Australian women diagnosed with breast cancer undergo a 
total mastectomy 62. One possible explanation for this result in 
the study may be that the information is presented differently 
in a clinical setting when women are actually given a definitive 
diagnosis of early breast cancer and told that radiation treatment 
can be between six to nine weeks, as opposed to undergoing 
one operation. Because treatment outcome values were rated 
highest, diagnosed women may unconsciously choose the 
treatment (mastectomy) that they believe will best fulfill 
these values. Success of outcome appears more important than 
problems with body image despite the rational knowledge that 
both treatments are equal in outcome. 
Women who  have chosen a mastectomy often experience 
more difficulty with their self image and self esteem, whereas 
women with conservation surgery are often more concerned 
with a recurrence of breast cancer 50. Consequently, nurses also 
need to provide women with information about the newer 
and safer techniques for breast reconstruction 63. Individualised 
assessment of women’s social support, resourcefulness and self 
esteem is essential to predict the wellbeing 64 and long-term 
psychological adjustment of women 22. 
While many Australian nurses report that information about 
the physical aspect of breast cancer is integral to the provision 
of nursing care, and that they understand psychological support 
is important, they also feel that they often do not have the 
skills and time to provide this support 65,66. In Australia, the role 
of specialist breast care nurses is evolving. More nurses in more 
locations can identify and care for women who are at increased 
risk of psychological morbidity 67,68. Women who are separated or 
divorced or financially disadvantaged by earning a low income 
have little social support or specific cultural needs 6
Socio-demographic variables
In the present study there was a positive correlations between 
participants' age treatment decision-making, and this is 
consistent with previous studies of women diagnosed with 
breast cancer 15,16,17. For example, younger women want more 
information than older women 17,69, although older women often 
are less knowledgeable about breast cancer 70. In addition, older 
women may not be as computer literate as younger women and 
nurses need to offer non-internet forms of information to meet 
individual preferences. Moreover, threatening information can 
lead to reacting in an adaptive or maladaptive manner. The 
order of the information may affect a women’s adaptation 71 and 
requires careful planning by nurses.
Employed women were more likely to choose radical surgical 
treatment. Women in the sample were on average younger 
(mean=53yrs) and well educated (33.8% with university 
education). Reasons for this finding are not clear, but may 
include women taking notice of the education campaigns and 
reading more in media reports about the side effects of breast 
cancer treatment. Furthermore, this result raises questions about 
the possible relationship between education levels and the 
processing of information by women. Possibly, they understood 
that some negative treatment consequences might be necessary 
to achieve health. Positive correlations were found between 
participants' university education and perceptions of themselves 
and their bodies.
Participants with a family history of breast cancer were more 
likely to hypothetically prefer treatment that did not have 
negative psychological consequences of sadness or depression. 
These women possibly have experienced an affected family 
member suffering significant psychological problems, such 
as depression and anxiety. Likewise, women with a family 
history of breast cancer often experience a significant level 
of psychological distress that requires counselling 72. There is 
evidence 73 that a woman's psychological state before breast 
cancer is one of the best predictors of adjustment following 
breast cancer treatment.
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Limitations
The limitations of this study were the convenience sampling 
method and the fact that the sample consisted of women who 
were undergoing routine mammography screening for breast 
cancer and had not been diagnosed with breast cancer. The 
participants were asked to imagine if they had been diagnosed 
with early breast cancer and to consider what factors would be 
important to them in choosing between the equal alternatives 
of mastectomy or lumpectomy (conservation surgery). 
However, many women who undergo routine mammography 
screening experience anxiety 74,75,76 and fear a diagnosis of breast 
cancer 75,77. The possible implications of being diagnosed with 
cancer are usually to the fore in a woman’s mind at the time of 
mammography screening. Therefore, the results are probably 
similar to what they would report if they were diagnosed with 
early breast cancer. 
The participants responded to questions while undergoing some 
stress from the mammography screening, but not necessarily 
the intense psychological distress experienced by women newly 
diagnosed with breast cancer. Therefore, the participants may 
have been able to process the treatment information more 
effectively and match their treatment choices with their values, 
preferences and belief system better than those in distress, and 
possibly make better decisions. The sample reflected a higher 
percentage than the general population of women who were 
university educated. Further research is required to examine the 
influence of education in women’s treatment values. However, 
the findings suggest that factors influencing choice of medical 
treatment vary dramatically. Therefore, it is recommended that 
women receive individual assessment by nurses to determine 
their values, access to information, problem solving ability and 
desired level of engagement in decisions and decision support, 
when choosing medical treatment for early breast cancer.
Conclusion
This preliminary study provides baseline data about Australian 
women’s unaided prediagnostic decision-making values for early 
breast cancer treatment. Participants in the study indicated 
that if they were hypothetically diagnosed with early breast 
cancer, treatment outcomes were the most important deciding 
consideration. Other treatment factors, such as the side effects 
and emotional consequences, were less important. Therefore, it 
is imperative that nurses assess the values and preferences that 
a woman brings to the decision-making process of treatment 
choice for early breast cancer. In addition, nurses should assess 
a woman’s understanding and access to important information 
relating to treatment options and her ability to problem solve 
in designing an action plan with her doctor. Nurses need to 
provide focused information supports that frame the problems of 
each treatment alternative, so women can clearly differentiate 
between treatment options and make decisions that match their 
values and lifestyle, and use the current evidence available, such 
as the Psychosocial Clinical Practice Guidelines for women 
with breast cancer developed by the National Breast Cancer 
Centre 12.
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